NewGenIvf Group (NIVF) Stock Price, News & Analysis

Company Overview

NewGenIvf Group Limited is a fertility-services company that provides assisted reproductive and related medical services. Through its NewGen IVF network, the company serves individuals and couples seeking fertility evaluation, in vitro fertilization (IVF), and other treatments designed to support conception.

Its services include fertility consultations and diagnostic testing, ovarian stimulation, egg retrieval, embryo transfer, intracytoplasmic sperm injection (ICSI), embryo and reproductive-cell freezing, and preimplantation genetic testing. The company also offers fertility preservation and related programs, subject to applicable medical and regulatory requirements.

NewGenIvf Group is headquartered in Thailand and focuses primarily on patients in Thailand and the broader Southeast Asian market. The company’s operations are centered on fertility clinics and supporting laboratory services. Publicly available information about its corporate history and leadership is limited, so additional details are not included here.

Key Stats

• Today's Range: $0.11 to $0.16
• 50-Day Range: $0.07 to $3.15
• 52-Week Range: $0.06 to $1,539.00
• Volume: 300.30 million shs
• Average Volume: 65.19 million shs
• Market Capitalization: $270.90 thousand
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

NewGenIvf Group Stock Analysis - MarketRank™

NewGenIvf Group scored higher than 63% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.7 / 5
• Analyst Rating: Sell

Consensus Rating

NewGenIvf Group has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

NewGenIvf Group has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 97.05%

Earnings Growth

Earnings for NewGenIvf Group are expected to grow by 97.05% in the coming year, from $42.67 to $84.08 per share.

Price to Book Value per Share Ratio

NewGenIvf Group has a P/B Ratio of 0.00. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 5.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.15% of the float of NewGenIvf Group has been sold short.

Short Interest Ratio / Days to Cover

NewGenIvf Group has a short interest ratio ("days to cover") of 0.15, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in NewGenIvf Group has recently decreased by 81.99%, indicating that investor sentiment is improving significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

NewGenIvf Group does not currently pay a dividend.

Dividend Growth

NewGenIvf Group does not have a long track record of dividend growth.

News and Social Media

• Score: 3.4 / 5
• News Sentiment: 0.43

News Sentiment

NewGenIvf Group has a news sentiment score of 0.43. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for NewGenIvf Group this week, compared to 2 articles on an average week.

Search Interest

1 people have searched for NIVF on MarketBeat in the last 30 days.

MarketBeat Follows

1 people have added NewGenIvf Group to their MarketBeat watchlist in the last 30 days.

Company Ownership

• Score: 4.3 / 5
• Insider Trading: Acquiring Shares

Net Insider Buying

Over the last three months, insiders have purchased a net $2,500,000.00 in company stock, which represents 922.8498% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, NewGenIvf Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $2,500,000.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

31.80% of the stock of NewGenIvf Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

66.24% of the stock of NewGenIvf Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Today: 10/04/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Healthcare Providers & Services
• Sub-Industry: Healthcare Services
• Current Symbol: NASDAQ:NIVF
• Previous Symbol: NASDAQ:NIVF
• CIK: 1981662
• Web: www.nivf.global
• Phone: 65-6818-5796
• Fax: N/A
• Employees: 87
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $4.73 million
• Price / Sales: 0.06
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $952.22 per share
• Price / Book: 0.00

Miscellaneous

• Outstanding Shares: 2,100,000
• Free Float: 1,434,000
• Market Cap: $270.90 thousand
• Optionable: N/A
• Beta: 0.07